Heidi raises $340M at $900M valuation
Analysis based on 7 articles · First reported Sep 22, 2026 · Last updated Sep 23, 2026
The round signals continued strong venture appetite for healthcare AI, lifting sentiment for clinical documentation and agentic healthcare software peers and their investors. It pressures competitors such as Ambience Healthcare, Abridge, and Microsoft-owned Nuance, while validating the enterprise SaaS growth trajectory that underpins Heidi's $900 million valuation.
Heidi, an Australian healthcare technology company founded in Melbourne in 2021 by Dr. Thomas Kelly, Waleed Mussa, and Liu Yu, announced on September 22, 2026 a $340 million funding package valuing the company at $900 million. The package comprises a $100 million Series C equity round led by Blackbird II ApS with participation from existing investors Phoenix Court, Point72 Asset Management, and Headline, plus a separate $240 million growth investment led by General Catalyst's Customer Value Fund. The capital will fund global expansion and development of supervised AI agents that handle administrative and clinical workflows under physician oversight, moving Heidi beyond its original AI clinical documentation scribe. Heidi's platform reportedly supports approximately 2.8 million patient visits per week across 190 countries and 110 languages, and has supported more than 175 million patient visits and over 67 million clinical hours since launch. Annual recurring revenue reportedly grew from $1 million to $50 million in about two years, reaching that level in April 2026. Deployments include Beth Israel Lahey Health in the United States, Bret Engemann Midlands in the United Kingdom as sole supplier, The Royal Children s Hospital, Australia — Queensland Children s Hospital, and Australia — Metro South Health in Australia, and every emergency department in New Zealand. Heidi also named Toronto as its North American headquarters and partnered with R1 RCM to integrate its documentation technology into R1's revenue operating system. Dr. Simon Kos, formerly Chief Medical Officer at Microsoft, joined as Heidi's CMO during the Series B round. The company said forthcoming agentic capabilities will not be available in the United Kingdom or European Union.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard